Gębura Katarzyna, Świerkot Jerzy, Wysoczańska Barbara, Korman Lucyna, Nowak Beata, Wiland Piotr, Bogunia-Kubik Katarzyna
Laboratory of Clinical Immunogenetics and Pharmacogenetics, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland.
Department of Rheumatology and Internal Medicine, Wroclaw Medical University, 50-556 Wrocław, Poland.
Int J Mol Sci. 2017 Jul 4;18(7):1432. doi: 10.3390/ijms18071432.
Genes involved in regulation of the nuclear factor-κB (NF-κB)-pathway are suggested to play a role in pathogenesis of rheumatoid arthritis (RA). In the present study, genetic polymorphisms of , , and genes were investigated to assess their associations with RA susceptibility, progression and response to anti-TNF-α therapy. A group of 110 RA patients and 126 healthy individuals were genotyped for (rs111200466), (rs4986790, rs4986791), (rs5743836, rs187084) and (rs28362491) alleles. The presence of the -1486 variant ( < 0.0001) and its homozygosity ( < 0.0001) were found to be associated with disease susceptibility. The -1237 allele was associated with predisposition to RA in females only ( = 0.005). Moreover, the rs4986791 (rs4986790 ) alleles were more frequently detected among patients with the stage IV disease ( = 0.045), and were associated with more effective response to anti-TNF-α therapy ( = 0.012). More efficient response to anti-TNF-α treatment was also observed in patients with within the gene ( = 0.047), while for the -1486 homozygotes, the treatment was ineffective ( = 0.018). polymorphisms affect disease susceptibility and response to therapy with TNF-α inhibitors in RA patients of Caucasian origin.
参与核因子-κB(NF-κB)信号通路调控的基因被认为在类风湿关节炎(RA)的发病机制中发挥作用。在本研究中,对[具体基因名称未给出]、[具体基因名称未给出]、[具体基因名称未给出]和[具体基因名称未给出]基因的遗传多态性进行了研究,以评估它们与RA易感性、疾病进展及抗TNF-α治疗反应的相关性。对110例RA患者和126名健康个体进行基因分型,检测[具体基因名称未给出](rs111200466)、[具体基因名称未给出](rs4986790、rs4986791)、[具体基因名称未给出](rs5743836、rs187084)和[具体基因名称未给出](rs28362491)等位基因。发现[具体基因名称未给出]-1486变体的存在(P<0.0001)及其纯合性(P<0.0001)与疾病易感性相关。[具体基因名称未给出]-1237等位基因仅在女性中与RA易感性相关(P = 0.005)。此外,[具体基因名称未给出]rs4986791(rs4986790)等位基因在IV期疾病患者中更频繁检测到(P = 0.045),并且与抗TNF-α治疗的更有效反应相关(P = 0.012)。在[具体基因名称未给出]基因内存在[具体基因名称未给出]的患者中也观察到对抗TNF-α治疗更有效的反应(P = 0.047),而对于[具体基因名称未给出]-1486纯合子,治疗无效(P = 0.018)。[具体基因名称未给出]多态性影响白种人来源RA患者的疾病易感性和对TNF-α抑制剂治疗的反应。